Jan 4, 2012

Cellular Dynamics International to Present at 30th Annual JPMorgan Healthcare Conference

Dec 13, 2011

Cellular Dynamics Announces Commercial Launch of iCell Neurons for Neuroscience Drug Discovery

Dec 5, 2011

Roche, ChanTest Collaborate for Preclinical Cardiac Safety Testing of Drug compounds Using iCell Cardiomyocytes and xCELLigence RTCA Cardio Instrument

Oct 17, 2011

Cellular Dynamics International's (CDI) Human Induced Pluripotent Stem Cell (iPSC) Technology Named the Gold Winner in The Wall Street Journal 2011 Technology Innovation Awards

Sep 20, 2011

Cellular Dynamics Announces Commercial Launch of iCell Endothelial Cells for Vascular-targeted Drug Discovery

Aug 11, 2011

Cellular Dynamics Launches Innovative Research Grant Program

Jul 5, 2011

Medical College of Wisconsin and Cellular Dynamics Awarded NHLBI Grant Using Human Induced Pluripotent Stem Cells

Jun 27, 2011

Cellular Dynamics International Unlocks the Potential of Banked Blood Samples

Jun 8, 2011

iPS Academia Japan, Inc. to Distribute Cellular Dynamics' iCell^® Products in Japan

Apr 13, 2011

Cellular Dynamics Licenses Technology from ViaCyte

Apr 7, 2011

Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells

Apr 1, 2011

Midas Mediscience and Cellular Dynamics Collaborate to Expand Commercial Use of Human Stem Cell-Based Assays for Predicting Drug-Induced Cardiotoxicity

Mar 22, 2011

Cellular Dynamics International and Roche Transition Early Access Collaboration into a Standard Supply Agreement Ahead of Schedule

Mar 4, 2011

Cellular Dynamics International Scientists Report on Efficient Method to Produce Footprint-Free Induced Pluripotent Stem Cells (iPSCs) Under Feeder-Free Condition

Mar 3, 2011

Cellular Dynamics International Presents Data Demonstrating the Utility of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes as Human Cell Models at the Society of Toxicology 50^th Annual Meeting & ToxExpo

Jan 6, 2011

Cellular Dynamics International to Present at 29^th Annual JPMorgan Healthcare Conference

Dec 1, 2010

The Scientist Magazine Recognizes Cellular Dynamics International’s iCell^® Cardiomyocytes Among the Winners of “Top 10 Innovations of 2010”

Nov 4, 2010

Cellular Dynamics Awarded Four Therapeutic Discovery Grants Totaling Almost $978,000 for Induced Pluripotent Stem Cell Programs

Sep 16, 2010

Cellular Dynamics International, ACEA Biosciences, and Roche Applied Sciences Cooperate to Evaluate iCell Cardiomyocytes on the xCELLigence System

June 15, 2010

Promega and Cellular Dynamics Partner to Validate Stem Cell-Based In Vitro Assays for Predicting Drug-Induced Cardiotoxicity

May 7, 2010

Cellular Dynamics Partners with iPS Academia Japan, Inc. to In-License Seminal iPS Cell Patent Portfolio

Apr 27, 2010

Cellular Dynamics Raises $40.6 MM to Revolutionize Pharma Drug Research with Industrial Manufacture of Human Heart and Other Cells

Apr 21, 2010

Cellular Dynamics International’s iCell^® Cardiomyocytes, Derived From Human iPSCs, Named to MIT Technology Review’s Annual 10 Emerging Technologies List

Mar 3, 2010

Cellular Dynamics and Roche Conduct “Stem Cells in Drug Discovery and Development” Workshop at the Society of Toxicology Annual Meeting

Dec 16, 2009

Cellular Dynamics Announces Commercial Launch of iCell^® Cardiomyocytes for Drug Candidate Toxicity Screening

Sep 14, 2009

Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testing

Aug 12, 2009

Cellular Dynamics International Appoints Leroy Hood, M.D., Ph.D., and George Church, Ph.D., to its Scientific Advisory Board

July 22, 2009

Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International

July 15, 2009

Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing

July 8, 2009

Cellular Dynamics International Reprograms Blood Cells into Stem Cells

July 1, 2009

Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement

May 27, 2009

Cellular Dynamics Licenses Key Patent Portfolio Surrounding Cardiovascular Progenitor Cells

Dec 16, 2008

Cellular Dynamics International Appoints New Commercial, Operations and Financial Leadership

Nov 24, 2008

Cellular Dynamics International Merges Companies, Closes on $18 Million Financing

Nov 14, 2008

NIH Awards Cellular Dynamics International SBIR Grant to Develop Human Cardiomyocytes for Drug Screening

Nov 6, 2008

Cellular Dynamics International Awarded $500,000 SBIR Grant for Hematopoietic Stem Cell Research

Mar 5, 2008

Cellular Dynamics International and Roche Palo Alto Enter Agreement to Screen Drug Compounds for Cardiotoxicity